About
Footstep ahead.
Diawin is a renowned manufacturer of preventive orthopedic footwear, enhancing the lives of diabetics and people with unique foot needs. Our products merge scientific insights and design with a profound understanding of diabetic requirements, aiming to be a symbol of empathy and responsibility in the footwear industry.
Our Story
Our inception was rooted in deep professional and personal experiences with diabetic patients, leading to the creation of footwear tailored to their specific needs. Since 2017, Diawin has been recognized as a medical aid in Slovakia and expanded into the Ukrainian market in 2018. By 2023, our footwear was acknowledged as a medical device for diabetics with neuropathy in the Czech Republic, furthering our reach across Europe, including Germany, France, Italy, and Spain through Amazon.
Tens of thousands of European diabetics affirm the effectiveness of our footwear. Clinical studies show a significant reduction in reulceration risks by up to 78.28%, supported by the Slovak Diabetic Society's endorsement. Our products, known for therapeutic benefits and modern design, offer immediate, comfortable, and stylish footwear solutions.
All Diawin products are CE certified and TÜV tested, ensuring safety and quality. We value customer feedback and continuously strive to enhance their experience. Diawin is more than a footwear manufacturer; we are committed partners and community supporters, dedicated to empowering those facing diabetes challenges with our ethical, high-quality, and innovative solutions.
Tomas Janura
CEO Diawin
Diawin
About Diawin
We are an established manufacturer of prophylactic orthopedic footwear. We focus on improving the lives of people with atypical feet and diabetics. Our footwear is designed based on scientific knowledge and a deep understanding of our clients needs. Therefore, it is available in three widths for each size, ensuring an ideal adaptation to various foot shapes. Since 2017, it has been registered as a medical device in Slovakia and since 2023 also in the Czech Republic. Our entry into the Ukrainian market in 2018 and expansion into Germany, France, Italy, and Spain through Amazon demonstrates our growing trust and loyalty from the clients.
2016
Diawin
Several years of preparation involving analysis, clinical study, design, prototyping logically led to the creation of footwear certified as a Medical Device class I. under the Diawin brand. This brand was established with the aim of providing quality preventive orthopedic footwear specially designed for people with atypical feet and diabetics.
2017
Registration in Slovakia
Diawin footwear has been officially recognized as a medical device and included in the list of reimbursed medical device in the Slovak Republic. Soon after that, it has become a market leader in its category. Tens of thousands of Slovaks wear Diawin every day, confirming its popularity and trust among consumers.
2018
Ukraine
Use this space to promote the business, its products or its services. Help people become familiar with the business and its offerings, creating a sense of connection and trust.
2018—2023
Growth and Development in the EU
Professionalizing and designing processes and procedures to achieve the best possible user experience has become a priority. We are expanding! Especially in the mass-retail segment. In Germany, France, Italy, and Spain, we have achieved significant success, where customers have discovered Diawin brand footwear mainly through the Amazon platform, confirming our ambitions to grow and expand our presence in international markets.
2023
Registration
in Czech Republic
As part of our mission to provide accessible footwear for people with atypical feet and diabetes, Diawin continues to expand its reach. We have become a registered medical device for diabetics with neuropathy in the Czech Republic, covered by health insurance. This represents an important milestone in our expansion and commitment to improving the quality of life for our customers.
2023
Clinical Studies
Clinical studies confirm that wearing Diawin footwear can reduce the risk of reulceration.
A study tracking 82 diabetic patients with neuropathy, who wore Diawin footwear for 30
months, demonstrated a reduction in the risk of reulceration by up to 78.28%.